Who was studied, and how
One number in the abstract
Where each one falls
Where it lands on the map
What it changes
Among 23 other studies
3,417people with obesity, in this paper
The trial randomly assignedassigned by chance
cagrilintide-semaglutide
placebo
Lowered percent change in body weight from baseline to week 68−17.3
randomisedthe abstract, start to end
… with placebo (estimated difference, -17.3 percentage points; 95% …
← favours treatmentfavours comparator →
could be chanceMean percent change in body weight from baseline to week 68cagrilintide-semaglutide vs placebo
−17.3−18.1 to −16.6
GLP-1 receptor agonistsGIP/GLP-1 & amylin agonistsBody weight & composition
GIP/GLP-1 & amylin agonists × body weight & compositionhelps?replicated
unlikelylikely
1.001.00 without it
GLP-1 receptor agonists × body weight & compositionhelps?replicated
unlikelylikely
0.900.90 without it
← favours treatmentfavours comparator →
1 / 6